GeneDx Holdings (WGS) Cash & Equivalents Growth (1y) (2021 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 10.00% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 96.24% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -78.09% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 67.45% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 221.84% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -4.10% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 7.30% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 293.56% |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -18.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.62% |
| Mar 31, 2026 | -5.80% |
| Dec 31, 2025 | 23.22% |
| Sep 30, 2025 | 65.77% |
| Jun 30, 2025 | 32.18% |
| Mar 31, 2025 | 19.16% |
| Dec 31, 2024 | -14.52% |
| Sep 30, 2024 | -33.75% |
| Jun 30, 2024 | -64.21% |
| Mar 31, 2024 | -58.56% |
| Dec 31, 2023 | -19.57% |
| Sep 30, 2023 | -54.34% |
| Jun 30, 2023 | -44.95% |
| Mar 31, 2023 | -35.91% |
| Dec 31, 2022 | -69.06% |
| Sep 30, 2022 | -58.51% |
| Jun 30, 2022 | 974.10% |
| Mar 31, 2022 | 437.07% |
| Dec 31, 2021 | 270.44% |
| Sep 30, 2021 | 40,363.55% |